[Prostate cancer - Progression slowed in low-risk tumors]
- PMID: 23389906
- DOI: 10.1055/s-0033-1334833
[Prostate cancer - Progression slowed in low-risk tumors]
Comment on
-
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.Lancet. 2012 Mar 24;379(9821):1103-11. doi: 10.1016/S0140-6736(11)61619-X. Epub 2012 Jan 24. Lancet. 2012. PMID: 22277570 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
